Cargando…

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas

Excessive growth hormone (GH) is usually secreted by GH-secreting pituitary adenomas and causes gigantism in juveniles or acromegaly in adults. The clinical complications involving cardiovascular, respiratory, and metabolic systems lead to elevated morbidity in acromegaly. Control of serum GH and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ji-wen, Li, Ying, Mao, Zhi-gang, Hu, Bin, Jiang, Xiao-bing, Song, Bing-bing, Wang, Xin, Zhu, Yong-hong, Wang, Hai-jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888346/ https://www.ncbi.nlm.nih.gov/pubmed/24421637 http://dx.doi.org/10.2147/PPA.S53930

Ejemplares similares

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

Gigantism caused by growth hormone secreting pituitary adenoma
por: Rhee, Noorisaem, et al.
Publicado: (2014)

Differential expression of microRNAs in GH-secreting pituitary adenomas
por: Mao, Zhi-Gang, et al.
Publicado: (2010)

Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma
por: Wang, Meng, et al.
Publicado: (2022)

Outcome of Endoscopic Transsphenoidal Surgery in Combination with Somatostatin Analogues in Patients with Growth Hormone Producing Pituitary Adenoma
por: Zhou, Tao, et al.
Publicado: (2014)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
por: Bianchi, Antonio, et al.
Publicado: (2013)

Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
por: Liu, Jie, et al.
Publicado: (2022)

Collision tumors composed of meningioma and growth hormone-secreting pituitary adenoma in the sellar region: Case reports and a literature review
por: Zhao, Yi, et al.
Publicado: (2017)

Uric acid levels correlate with disease activity in growth hormone-secreting pituitary adenoma patients
por: Mo, Caiyan, et al.
Publicado: (2023)

In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells
por: Cuny, Thomas, et al.
Publicado: (2016)

SAT-276 Co-Secreting TSH and Growth Hormone Pituitary Adenoma
por: Eid, Hatem
Publicado: (2020)

Surgical management of growth hormone-secreting pituitary adenomas: A retrospective analysis of 33 patients
por: Zheng, Yong, et al.
Publicado: (2020)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study
por: Chen, Zhiyong, et al.
Publicado: (2018)

Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells
por: An, Jiayin, et al.
Publicado: (2017)

Surgical Outcome and Evaluation of Strategies in the Management of Growth Hormone-Secreting Pituitary Adenomas After Initial Transsphenoidal Pituitary Adenectomy Failure
por: Yan, Jiun-Lin, et al.
Publicado: (2022)

Transformation of a Microprolactinoma into a Mixed Growth Hormone and Prolactin-Secreting Pituitary Adenoma
por: Dessimoz, Cédric, et al.
Publicado: (2012)

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma
por: Shi, Chengzhang, et al.
Publicado: (2020)

THU063 Somatostatin Analog Neoadjuvant Treatment Before Endoscopic Surgery For Growth-Hormone Producing Pituitary Adenomas Invading The Cavernous Sinus: Case Series, Systematic Literature Review And Meta-analysis
por: Rapoport, Benjamin, et al.
Publicado: (2023)

Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenoma in the Clivus Region: A Case Report
por: Zhang, Yan, et al.
Publicado: (2022)

Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report
por: Yang, Jing, et al.
Publicado: (2017)

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis
por: Ichijo, Masashi, et al.
Publicado: (2019)

Surgical management of pituitary adenoma during pregnancy
por: Jia, Xin-Yu, et al.
Publicado: (2023)

The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma
por: Ji, Chenxing, et al.
Publicado: (2022)

Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics
por: Liu, Chen-Xi, et al.
Publicado: (2022)

Preoperative Extrapontine Myelinolysis with Good Outcome in a Patient with Pituitary Adenoma
por: Zhou, Ying, et al.
Publicado: (2016)

Refractory pituitary adenoma: a novel classification for pituitary tumors
por: Dai, Congxin, et al.
Publicado: (2016)

TBR-760, a Dopamine-Somatostatin Compound, Arrests Growth of Aggressive Nonfunctioning Pituitary Adenomas in Mice
por: Halem, Heather A, et al.
Publicado: (2020)

ODP286 A Case of Synchronous Growth Hormone and Adrenocorticotrophic Hormone Secretion in a Patient with an Incidental Pituitary Adenoma.
por: Maraqa, Sima, et al.
Publicado: (2022)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

Granulomatous hypophysitis caused by Rathke's cleft cyst mimicking a growth hormone-secreting pituitary adenoma
por: Hojo, Masato, et al.
Publicado: (2017)

MON-303 Giant Growth Hormone Secreting Pituitary Adenomas: A Single Institution Case Series
por: Koylu, Bahadir, et al.
Publicado: (2020)

Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas
por: Caulley, Lisa, et al.
Publicado: (2022)

Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma
por: Tucker, Douglass W., et al.
Publicado: (2023)

Usefulness of the Texture Signatures Based on Multiparametric MRI in Predicting Growth Hormone Pituitary Adenoma Subtypes
por: Liu, Chen-Xi, et al.
Publicado: (2021)

The Marine Metabolite SZ-685C Induces Apoptosis in Primary Human Nonfunctioning Pituitary Adenoma Cells by Inhibition of the Akt Pathway in Vitro
por: Wang, Xin, et al.
Publicado: (2015)

Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas
por: Chin, Sang Ouk, et al.
Publicado: (2013)

The genome-wide mutational landscape of pituitary adenomas
por: Song, Zhi-Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sh0v2777n0o3ti35lsac083avm